In briefBMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7516.532 (Published 08 September 2005) Cite this as: BMJ 2005;331:532
WHO says monitor resistance to new malaria drugs: Countries have been urged by the World Health Organization to monitor closely the effectiveness of artemisinin based combination therapies, the recommended treatment option for countries where resistance to standard malaria drugs is a problem. See http://www.who.int/
Neglected disease research threatened: Public-private partnerships have been a critical driver of research into …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial